Johnson & Johnson's single-dose Covid-19 vaccine provides protection against severe infections

The United States Food and Drug Administration could grant emergency use authorization to Johnson & Johnson's single-dose Covid-19 vaccine as early as Saturday, bringing a third vaccine manufacturer to the United States. J&J submitted Covid vaccine data shows a 66% effectiveness overall (72% in the United States and 64% in South Africa) and prevents 100% of hospitalizations and deaths.